News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Durgesh Bhandary, MS

Articles by Durgesh Bhandary, MS

Translating Clinical Evidence Into Value-Based Payment Models: Pooled Analyses of Innovative Real-World Outcomes Agreements for Ticagrelor in the United States

ByDurgesh Bhandary, MS,Nipun Atreja, PhD, MS,Daniel A. Belletti, MA, BSN, RN,Narinder Bhalla, MD,Naeem D. Khan, MD,David S. Cobden, PhD, MPH, MSc, MBA

October 13th 2020

Medication Burden in Patients With Acute Coronary Syndromes

ByEric A. Wright, PharmD, MPH,Steven R. Steinhubl, MD,JB Jones, PhD, MBA,Pinky Barua, MSc, MBA,Xiaowei Yan, PhD,Ryan Van Loan, BA,Glenda Frederick, BA,Durgesh Bhandary, MS,David Cobden, Ph

April 20th 2017

Patients endure heavy medication complexity following hospital discharge for acute coronary syndrome.

Latest Updated Articles

Translating Clinical Evidence Into Value-Based Payment Models: Pooled Analyses of Innovative Real-World Outcomes Agreements for Ticagrelor in the United States
Published: October 13th 2020 | Updated:
Medication Burden in Patients With Acute Coronary Syndromes
Published: April 20th 2017 | Updated:

Trending on AJMC

Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer

How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis

Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL

Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS

The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.